
David R Snydman MD FACP, FIDSA, FAST (He/Him)
Emeritus Chief, Division of Geographic Medicine and Infectious Disease, Tufts Medical Center and Emeritus Vice Chair for Research, Department of Medicine, Professor of Medicine, Tufts University School of Medicine
Join to View Full Profile
750 Washington St# 836Boston, MA 02111
Phone+1 617-636-5000
Fax+1 617-636-6204
Dr. Snydman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Snydman is an infectious disease specialist in Boston, MA and is affiliated with Tufts Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 45 years. He is experienced in cytomegalovirus, c.diff colitis, nosocomial infections, transplant infectious disease, and transplant infections. He has more than 300 publications and over 20,000 citations. He has been awarded the Walter Stamm mentorship award from the Infectious Disease Society of America, and received a Citation from the Commonwealth of Massachusetts for his role in the development of Cytomegalovirus Immune Globulin. He has received a Distinguished Faculty award from Tufts University School of Medicine.
Education & Training
Tufts Medical Center1979
Tufts Medical CenterResidency, Internal Medicine, 1974
Perelman School of Medicine at the University of PennsylvaniaClass of 1972
Williams CollegeB.A., Cum Laude, Highest Honors in Chemistry, 1968
Certifications & Licensure
MA State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Americas Best Doctors Selection 2008-2016
- Walter E. Stamm Mentor Award Infectious Diseases Society of America, 2015
- Boston Magazine Castle Connolly, 2010-2015
Clinical Trials
- Probiotic Lactobacillus GG to Eliminate VRE Colonization Start of enrollment: 2003 Mar 01
- Letermovir Use in Heart Transplant Recipients Start of enrollment: 2022 Jan 05
Roles: Principal Investigator, Contact
- Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Start of enrollment: 2023 Feb 02
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Cytomegalovirus Viral Load Dynamics and Outcomes After Liver Transplantation in Moderate and Low Risk Patients Treated With Cytomegalovirus Immune Globulin Prophylaxis.Jennifer K L Chow, Laura McDermott, David R Snydman
Journal of Medical Virology. 2026-04-01 - Response to "Letermovir prophylaxis and CMV immune monitoring: Toward a win-win strategy in heart transplantation".Jennifer K L Chow, David R Snydman
The Journal of Heart and Lung Transplantation. 2026-02-01 - 5 citationsTolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation.Jennifer K L Chow, Amanda R Vest, David DeNofrio, David R Snydman
The Journal of Heart and Lung Transplantation. 2026-01-01
Journal Articles
- Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantationKotton CN, Kumar D, Caliendo AM, Asberg A, Chou S Danziger-Isakov L, Humar A; Transplantation Society International CMV Consensus Group, Transplantation, 1/1/2013
- Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of Medicine, 11 June 2007Snydman DR, Clinical Infectious Disease, 1/1/2010
- Introduction Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of MedicineSnydman DR, Clinical Infectious Disease, 1/1/2010
Books/Book Chapters
Abstracts/Posters
- D-1151 - Antibiotic Resistance among Bacteroides spp. And Evolving Multidrug-Resistance.D.R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
- In Vitro Activity of Surotomycin Tested Against 885 Isolates of Clostridium difficile Collected as part of a National Surveillance Program 2011-2012.D.R. Snydman, L.A. McDermott, N.V. Jacobus, S.G. Jenkins, E.J.C. Goldstein, R. Patel, B.A. Forbes, S. Mirrett, D.W. Hecht, R. Goering, C. Thorpe, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
- T-2031- Cost Burden of Cytomegalovirus (CMV) Disease Among Solid Organ Transplant Recipients.H. Yang, D. Zhuo, Z. Zhou, E. Q. Wu, P. Chaudhari, D. R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
Other
- State-of-the-Art Management of CMV Infection and Disease in Transplant Recipients. CME slide kit, CD Rom, and web site for education.David R. Snydman and Robert H. Rubin, Synermed Coomunications and the Dannemiller Memorial Education Foundation
http://www.cmvlink.com
1/1/2006 - Hypogammaglobulinemia in organ transplantation 2005. A continuing education program sponsored by Tufts University.David R. Snydman, Robin K. Avery, Shira Doron, Arthur R. Rabson, Mohamad H. Yamani, Bramnick and Associates, New York, NY
1/1/2005 - Transplantation Related InfectionsSnydman DR, Tufts University School of Medicine
1/1/2000
Press Mentions
2015 AST FAST DesigneesMay 21st, 2015
Grant Support
- Clincal Research Training In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2010–2011
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Complementary &Alternative Medicine2006–2010
- Clinical Research Training In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2005–2009
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Research Resources2005
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Complementary &Alternative Medicine2004–2005
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









